RHEOS
Dead / Abandoned — Abandoned — no statement of use filed (as of 07 Nov 2022)
What this means for you
This application is over — abandoned 07 Nov 2022. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90121499
- Mark type
- Word mark
- Filed
- 18 Aug 2020
- Published for opposition
- 10 Aug 2021
- Abandoned
- 07 Nov 2022
- Attorney of record
- Douglas R. Wolf
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations for the treatment of autoimmune diseases, inflammation, and cancer; pharmaceutical preparations that modulate immune cell metabolism; pharmaceutical preparations for the treatment of immune-mediated diseases; pharmaceutical preparations that modulate immune cell metabolism and function
Owner
- Rheos Medicines, Inc., Cambridge, MA, US
- Rheos Medicines, Inc., Cambridge, MA, US
Prior registrations
Prosecution history
- 07 Nov 2022 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 07 Nov 2022 — ABANDONMENT - NO USE STATEMENT FILED
- 09 Mar 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 07 Mar 2022 — SOU EXTENSION 1 GRANTED
- 07 Mar 2022 — SOU EXTENSION 1 FILED
- 07 Mar 2022 — SOU TEAS EXTENSION RECEIVED
- 05 Oct 2021 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 10 Aug 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 10 Aug 2021 — PUBLISHED FOR OPPOSITION
- 21 Jul 2021 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 01 Jul 2021 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 15 Jun 2021 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 14 Jun 2021 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 14 Jun 2021 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 29 Dec 2020 — NOTIFICATION OF NON-FINAL ACTION E-MAILED